. 2020 Dec 1;17(23):8942. doi: 10.3390/ijerph17238942

Table 5.

Brachial and femoral artery flow-mediated dilation (FMD) at the start (PRE) and following (POST) the 8 week Control and Intervention trials (mean ± SD).

	Control		Within- Group Differences	Intervention		Within- Group Differences	Between- Group Differences	Cohen’s d
	PRE	POST	Within- Group Differences	PRE	POST	Within- Group Differences	Between- Group Differences	Cohen’s d
Brachial Artery
Baseline Diameter (cm)	0.34 ± 0.09	0.34 ± 0.09	0.00 ± 0.02	0.36 ± 0.08	0.35 ± 0.09	−0.01 ± 0.02	−0.01 ± 0.03	0.52
FMD (%)	6.1 ± 3.6	7.3 ± 4.3	1.2 ± 3.4	6.5 ± 3.9	7.9 ± 4.5	1.4 ± 5.8	0.2 ± 6.2	0.04
Absolute FMD (cm)	0.02 ± 0.01	0.02 ± 0.01	0.00 ± 0.01	0.02 ± 0.01	0.03 ± 0.01	0.01 ± 0.02	0.01 ± 0.02	0.66
SR AUC (s⁻¹ × 10³)	23.58 ± 12.34	26.09 ± 9.06	2.50 ± 10.95	27.15 ± 16.07	26.18 ± 12.20	−0.97 ± 18.86	−3.48 ± 19.89	0.23
Femoral Artery
Baseline Diameter (cm)	0.63 ± 0.15	0.61 ± 0.12	−0.02 ± 0.05	0.62 ± 0.14	0.61 ± 0.15	−0.01 ± 0.03	0.01 ± 0.06	0.25
FMD (%)	6.5 ± 2.7	5.9 ± 4.3	−0.6 ± 4.4	5.3 ± 3.2	10.5 ± 6.3	5.2 ± 6.7	5.8 ± 6.9	1.06
Absolute FMD (cm)	0.04 ± 0.01	0.04 ± 0.02	0.00 ± 0.03	0.03 ± 0.02	0.06 ± 0.03	0.03 ± 0.04	0.03 ± 0.05	0.88
SR AUC (s⁻¹ × 10³)	19.27 ± 10.89	16.86 ± 5.89	−2.41 ± 9.88	19.21 ± 12.26	20.16 ± 11.08	0.95 ± 12.42	3.37 ± 12.70	0.31

SR—shear rate; AUC—area under the curve.